The cost of tobacco-related diseases for Brazil's Unified National Health System;Os custos de doenças tabaco-relacionadas para o Sistema Único de Saúde

Cadernos de Saude Publica

Volumn 26, Issue 6, 2010, Pages 1234-1245

  Pinto, Márcia ^a   Ugá, Maria Alicia Domínguez ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Drug therapy; Health care costs; Hospitalization; Smoking

Indexed keywords

EID: 77955002615     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2010000600016     Document Type: Article

References (43)

1. World Health Organization. WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization; 2008.
2. Pan American Health Organization. Health in the Americas. 2002 edition. Washington DC: Pan American Health Organization; 2002.
3. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q 1982; 60:429-62.
4. Yang MC, Fann CT, Wen CP, Cheng TY. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control 2005; 14:62-70.
5. Xiao X, Robson L, Single E, Rehm J, Paul J. The economic consequences of smoking in Ontario. Pharmacol Res 1999; 39:185-91.
6. Ruff LK, Volmer T, Nowak D, Meyer A. The economic impact of smoking in Germany. Eur J Respir Dis 2000; 16:377-8.
7. Neubauer S, Welte R, Beiche A, Koenig H-H, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control 2006; 15:464-71.
8. John RM, Sung H-U, Max W. Economic cost of tobacco use in India, 2004. Tob Control 2009; 18: 138-43.
9. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. 2nd Ed. New York: Oxford University Press; 1996. p. 176-213.
10. Garber AM, Weinstein MC, Torrance GW, Kamlet MS. Theoretical foundations of cost-effectiveness analysis. In: Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. 2nd Ed. New York: Oxford University Press; 1996. p. 25-53.
11. Kobelt G. A economia da saúde: uma introdução à avaliação econômica em saúde. 2a Ed. London: Office of Health Economics; 2008.
12. Segel JE. Cost-of-illness studies: a primer. Research Triangle Park: RTI-UNC Center of Excellence in Health Promotion Economics; 2006.
13. Rubenstein LM, Chrischilles EA, Voelker MD. The impact of Parkinson's disease on health status, health expenditures, and productivity: estimates from the National Medical Expenditure Survey. Pharmacoeconomics 1997; 12:486-98.
14. Swensen A, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A. Attention deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 2003; 42:1415-23.
15. Centers of Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 1997-2001. MMWR Morb Mortal Wkly Rep 2005; 54:625-8.
16. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Resp J 1996; 9:636-42.
17. Luce BR, Schweitzer SO. Smoking and alcohol abuse: a comparison of their economic consequences. N Engl J Med 1978; 298:569-71.
18. Office of Technology Assessment, U.S. Congress. Smoking related deaths and financial costs. Washington DC: U.S. Government Printing Office; 1985.
19. Shultz JM, Novotny TE, Rice DP. Quantifying the disease impact of cigarette smoking with SAMMEC II software. Public Health Rep 1991; 106:326-33.
20. Oster G, Colditz GA, Kelly NL. The Economic costs of smoking and benefits of quitting for individual smokers. Prev Med 1994; 13:377-89.
21. Leu RE, Schaub T. More on impact of smoking on medical care expenditures. Soc Sci Med 1985; 21: 825-7.
22. Manning WG, Keeler EB, Newhouse JP, Sloss EM, Wasserman J. The taxes of sin: do smokers and drinkers pay their way? JAMA 1989; 261:1604-9.
23. Manning WG, Keeler EB, Newhouse JP, Sloss EM, Wasserman J. The cost of poor health habits. Cambridge: Harvard University Press; 1991.
24. Collins DJ, Lapsley H. Estimating and disaggregating the social costs of tobacco. In: Abedian I, van der Merwe R, Wilkins N, Jha P, editors. The economics of tobacco control: towards an optimal policy mix. Cape Town: Applied Fiscal Research Centre, University of Cape Town; 1998.
25. World Bank. Curbing the epidemic: governments and the economics of tobacco control. Washington DC: International Bank for Reconstruction and Development/World Bank; 1999.
26. Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. J Natl Cancer Inst Monogr 1985; 67:49-52.
27. Garfinkel L, Stellman SD. Smoking and lung cancer in women: findings in a prospective study. Cancer Res 1998; 48:6951-5.
28. Stellman SD, Garfinkel. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 1986; 76:1057-63.
29. Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001; 49:1-32.
30. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9:531-41.
31. Hanley J. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001; 55:508-14.
32. Centers for Disease Control and Prevention. Perspectives in disease prevention and health promotion. Smoking-attributable mortality and years of potential life lost-United States, 1984. MMWR Morb Mortal Wkly Rep 1987; 36:693-7.
33. Szwarcwald CL, Viacava F, Vasconcellos MTL, Leal MC, Azevedo LO, Queiroz RSB, et al. Pesquisa Mundial de Saúde 2003: o Brasil em números. Radis 2004; (23):14-33.
34. Gajalakshmi CK, Jha P, Ranson K, Nguyen S. Global patterns of smoking and smoking-attributable mortality. In: Jha P, Chaloupka F, editors. Tobacco control in developing countries. New York: Oxford University Press; 2000. p. 9-39.
35. Kessler DA, Natanblut SL, Wilkenfeld JP, Lorraine CC, Mayl SL, Bernstein IB, et al. Nicotine addiction: a pediatric disease. J Pediatr 1997; 130: 518-24.
36. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362:847-52.
37. Departamento de Informática do SUS. Movimento de Autorização de Internação Hospitalar. Arquivos reduzidos [CD-ROM]. Brasília: Ministério da Saúde; 2005.
38. Feijó MCC, Portela MC. Variação no custo de internações hospitalares por lesões: os casos dos traumatismos cranianos e acidentes por armas de fogo. Cad Saúde Pública 2001; 17:627-37.
39. Jorge MHPM, Koizumi MS. Gastos governamentais do SUS com internações hospitalares por causas externas: análise no Estado de São Paulo, 2000. Rev Bras Epidemiol 2004; 7:228-38.
40. Tobacco Free Initiative, World Health Organization. Building blocks for tobacco control: a handbook. Geneva: World Health Organization; 2004.
41. Harris JE. Cigarette smoking practices, smokingrelated diseases, and the costs of tobacco-related disability among currently living U.S. veterans. Washington DC: U.S. Department of Veterans Affairs; 1997.
42. Ross H, Trung DV, Phu VX. The costs of smoking in Vietnam: the case of inpatient care. Tob Control 2007; 16:405-9.
43. Aliança de Controle do Tabagismo. O veredicto final: trechos do processo Estados Unidos X Philip Morris. http://www.actbr.org.br (acessado em 03/Jul/2009).